MSH6 and astrocytoma (excluding glioblastoma): Therefore, survival analysis was performed in each treatment group separately and revealed that loss of MSH6 expression was significantly associated with longer overall survival in patients with high-grade astrocytomas treated with radiotherapy alone, whereas no differences were found in those patients that received radiotherapy plus chemotherapy.